Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Zealand Pharma gets DKK559.6mm via PIPE

Executive Summary

Peptide therapeutics developer Zealand Pharma AS raised DKK559.6mm ($82.2mm) through the private placement of 3.98mm new shares at DKK140.79 each (a 4% premium) to Van Herk Investments. The company will use the proceeds for ongoing R&D activities and to launch its first fully owned asset. Morgan Stanley was the placement agent.
Deal Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement
    • Private Investment in Public Equity

Related Companies